TECH Bio-Techne margins

Relative Growth: Rel. Growth: 69

Relative Strength: Rel. Strength: 73

Relative Valuation: Rel. Valuation: 30

Relative Profitability: Rel. Profitability: 90

Gross margin

65.8%

Operating margin

20.7%

EBITDA margin

28.6%

Net margin

15%

Using the latest TTM figures, Bio-Techne shows a gross margin of 65.8%, an operating margin of 20.7%, an EBITDA margin of 28.6%, and a net margin of 15%. The company's available margins all increased, with operating margin recording the strongest expansion of 12.3 percentage points.

TECH margin history

Gross, operating, EBITDA and net margin trends

Over the last 3 years, Bio-Techne recorded average margins of 65.76% gross, 15.55% operating, 24.6% EBITDA, and 11.98% net. The current gross, operating, EBITDA, and net margins are all above their three-year averages.

TECH margin expansion

Year-over-year margin changes in percentage points

All available margins expanded year over year, led by operating margin with an increase of 12.3 percentage points.

Gross margin expansion

1pp

Operating margin expansion

12.3pp

EBITDA margin expansion

10.8pp

Net margin expansion

9pp

TECH Gross margin

The average gross margin for Bio-Techne was 65.76% over the last 3 years. The current gross margin stands at 65.8%, 0 percentage points above its three-year average. The gross margin for Bio-Techne moved between 64.8% in Jun 2025 and 67.1% in Dec 2023.

TECH Operating margin

Across the last 3 years, Bio-Techne's operating margin averaged 15.55%. The current operating margin stands at 20.7%, 5.2 percentage points above its three-year average. Operating margin was highest at 23.5% in Dec 2023 and lowest at 8.4% in Jun 2025.

TECH EBITDA margin

Across the last 3 years, Bio-Techne had an average EBITDA margin of 24.6%. Against its three-year average, Bio-Techne's EBITDA margin is currently 28.6%, 4 percentage points above its three-year average. Looking back over the last 3 years, Bio-Techne's EBITDA margin reached 32.6% at its highest point in Dec 2023 and 17.8% at its lowest in Jun 2025.

TECH Net margin

Across the last 3 years, Bio-Techne's net margin averaged 11.98%. Compared with its three-year average, Bio-Techne's current net margin is 15% and is 3 percentage points above its three-year average. Net margin was highest at 19.6% in Dec 2023 and lowest at 6% in Jun 2025.

TECH margin group comparison

Margins compared with peer-group, industry and sector averages

With a gross margin of 65.8%, TECH stands higher than its peers average but lower than the Healthcare sector and the industry average. But when looking at the Healthcare sector average of 68.3%, Bio-Techne's gross margin is only 3.7% lower.

TECH margin peer comparison

Compare margins with selected peers

Frequently asked questions

What is Bio-Techne's gross margin?

The current gross margin for TECH is 65.8% as of Jun 30, 2026.

What is Bio-Techne's operating margin?

For the period ending Jun 30, 2026, TECH recorded an operating margin of 20.7%.

What is Bio-Techne's EBITDA margin?

As of Jun 30, 2026, TECH has an EBITDA margin of 28.6%.

What is Bio-Techne's net margin?

The current net margin for TECH is 15% as of Jun 30, 2026.

What are the average margins of TECH?

Looking back over 3 years, TECH recorded average margins of 65.8% gross, 15.6% operating, 24.6% EBITDA, and 12.0% net.

What are the highest historical margins of TECH?

Within the 5-year period, TECH recorded its highest margins at 68.5% gross in Sep 2022, 26.8% operating in Jun 2022, 41.2% EBITDA in Sep 2022, and 26.1% net in Sep 2022.

What are the lowest historical margins of TECH?

Bio-Techne's lowest recorded margins during the past 5 years were 64.8% gross in Jun 2025, 8.4% operating in Jun 2025, 17.8% EBITDA in Jun 2025, and 6% net in Jun 2025.